FTSE MIB
34.263,55 +323,80 (+0,95%) Dow Jones
38.085,80 -375,12 (-0,98%) Nasdaq
15.611,76 -100,99 (-0,64%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
84,16 +0,59 (+0,71%) Bitcoin EUR
59.838,21 +374,91 (+0,63%)
Cytosorbents Corporation (CTSO)
Dopo ore:
| Chiusura precedente | 0,8217 |
| Aperto | 0,8201 |
| Denaro | 0,7695 x 100 |
| Lettera | 0,8526 x 100 |
| Min-Max giorno | 0,8010 - 0,8630 |
| Intervallo di 52 settimane | 0,7820 - 4,2900 |
| Volume | |
| Media Volume | 100.938 |
| Capitalizzazione | 43,934M |
| Beta (5 anni mensile) | 0,59 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,6400 |
| Prossima data utili | 30 apr 2024 - 06 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 3,70 |
GlobeNewswireCytoSorbents to Present at the 8th Annual Dawson James Conference
PRINCETON, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Dawson James Small Cap Growth conference at the Wyndham Grand Jupiter at Harbourside Place in Jupiter, FL on Thursday, October 12th, 2023. Company management will also meet in-person with investors in
- GlobeNewswire
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
PRINCETON, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the upcoming original presentations at the 37th European Association of Cardio-Thoracic Surgery (EACTS) Annual Meeting in Vienna, Austria, from October 4-7, 2023, including the second analysis from the international Safe and T
GlobeNewswireDawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu
